NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in NGM Biopharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- −1 vs. Q3 2022
- Shares held
- 49.6M
- −572.5K (−1.1%) vs. Q3 2022
- Total value
- $248.9M
- −$407.1M (−62.1%) vs. Q3 2022
- New holders
- 24
- 62 more added
- Sold out
- 25
- 22 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 75 | $55.1M |
| Q4 2023 | 83 | $35.3M |
| Q3 2023 | 95 | $50.6M |
| Q2 2023 | 106 | $124.4M |
| Q1 2023 | 123 | $200.4M |
| Q4 2022 | 125 | $248.9M |
| Q3 2022 | 128 | $689.9M |
| Q2 2022 | 124 | $607.3M |
| Q1 2022 | 114 | $732.8M |
| Q4 2021 | 119 | $833.5M |
| Q3 2021 | 121 | $951.2M |
| Q2 2021 | 107 | $849.7M |
| Q1 2021 | 108 | $1.25B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding NGM Biopharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 279,190 | $1.40M | 0.00% | +19,250+7.4% | Added |
| Charles Schwab Investment Management Inc | 327,974 | $1.65M | 0.00% | +13,415+4.3% | Added |
| Two Sigma Advisers, LP | 329,500 | $1.65M | 0.00% | +42,800+14.9% | Added |
| Renaissance Technologies LLC | 343,500 | $1.72M | 0.00% | +69,300+25.3% | Added |
| Northern Trust Corp | 344,679 | $1.73M | 0.00% | +5,608+1.7% | Added |
| Jasper Ridge Partners, L.P. | 348,250 | $1.75M | 0.10% | +29,500+9.3% | Added |
| Candriam Luxembourg S.C.A. | 376,162 | $1.89M | 0.01% | +92,112+32.4% | Added |
| Goldman Sachs Group Inc | 379,658 | $1.91M | 0.00% | +46,019+13.8% | Added |
| Millennium Management LLC | 458,230 | $2.30M | 0.00% | +227,384+98.5% | Added |
| Boxer Capital, LLC | 500,000 | $2.51M | 0.14% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 547,865 | $2.75M | 0.00% | −239,943−30.5% | Reduced |
| JPMorgan Chase & Co | 566,539 | $2.85M | 0.00% | +32,642+6.1% | Added |
| Acadian Asset Management LLC | 581,223 | $2.91M | 0.01% | +581,223 | New |
| Morgan Stanley | 662,033 | $3.32M | 0.00% | +114,974+21.0% | Added |
| Jacobs Levy Equity Management, Inc | 673,164 | $3.38M | 0.02% | +604,515+880.6% | Added |
| State Street Corp | 704,551 | $3.54M | 0.00% | −151,024−17.7% | Reduced |
| Euclidean Capital LLC | 746,674 | $3.75M | 3.51% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 748,724 | $3.76M | 0.00% | +11,408+1.5% | Added |
| Nuveen Asset Management, LLC | 757,753 | $3.80M | 0.00% | +18,943+2.6% | Added |
| Rubric Capital Management LP | 877,161 | $4.40M | 0.19% | 00.0% | Unchanged |
| StepStone Group LP | 1,573,357 | $7.90M | 1.04% | 00.0% | Unchanged |
| BlackRock Inc. | 4,159,762 | $20.9M | 0.00% | +93,185+2.3% | Added |
| Vanguard Group Inc | 4,489,149 | $22.5M | 0.00% | +589,852+15.1% | Added |
| EcoR1 Capital, LLC | 6,435,518 | $32.3M | 0.98% | +5,894,410+1,089.3% | Added |
| The Column Group LLC | 18,136,735 | $91.0M | 30.31% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,798,100−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −955,505−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −850,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −362,900−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −316,256−100.0% | Sold out |
| Silvercrest Asset Management Group LLC | 0 | $0 | 0.00% | −176,125−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −132,426−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −122,430−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −94,517−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −74,953−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −61,970−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −51,863−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −48,046−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −35,245−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,400−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −25,700−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,757−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −11,919−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,768−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −7,407−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,290−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −3,260−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −2,058−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Ponoi Management, LLC | – | – | – | – | Not filed |
| Ponoi II Management, LLC | – | – | – | – | Not filed |